– Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2 asthma – –…
June 06, 2025 16:05 ET  | Source: PolyPid Ltd. PETACH TIKVA, Israel, June 06, 2025 (GLOBE NEWSWIRE) -- PolyPid…
Ad hoc announcement pursuant to Art. 53 LR At interim analysis, PSMAddition trial met its primary endpoint showing…
Sign in to your account